elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35993104-1A6AEAA9-55E1-4438-B134-5F3B3FAA4707
Q35993104-1A6AEAA9-55E1-4438-B134-5F3B3FAA4707
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35993104-1A6AEAA9-55E1-4438-B134-5F3B3FAA4707
Combination treatment with hypoxia-activated prodrug evofosfamide (TH-302) and mTOR inhibitors results in enhanced antitumor efficacy in preclinical renal cell carcinoma models.
P2860
Q35993104-1A6AEAA9-55E1-4438-B134-5F3B3FAA4707
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35993104-1A6AEAA9-55E1-4438-B134-5F3B3FAA4707
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e8c6eb6c5cf9246ed9b7c6cc013890e9bd67e4d1
P2860
Rules for making human tumor cells.